Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Soluble stroma-related biomarkers of pancreatic cancer.

Resovi A, Bani MR, Porcu L, Anastasia A, Minoli L, Allavena P, Cappello P, Novelli F, Scarpa A, Morandi E, Falanga A, Torri V, Taraboletti G, Belotti D, Giavazzi R.

EMBO Mol Med. 2018 Jun 25. pii: e8741. doi: 10.15252/emmm.201708741. [Epub ahead of print]

2.

Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF.

Belotti D, Capelli C, Resovi A, Introna M, Taraboletti G.

Matrix Biol. 2016 Sep;55:106-116. doi: 10.1016/j.matbio.2016.03.003. Epub 2016 Mar 16.

PMID:
26992552
3.

Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.

Martinelli GB, Olivari D, Re Cecconi AD, Talamini L, Ottoboni L, Lecker SH, Stretch C, Baracos VE, Bathe OF, Resovi A, Giavazzi R, Cervo L, Piccirillo R.

Oncogene. 2016 Dec 1;35(48):6212-6222. doi: 10.1038/onc.2016.153. Epub 2016 May 23.

PMID:
27212031
4.

PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1.

Pinessi D, Foglieni C, Bugatti A, Moroni E, Resovi A, Ribatti D, Rusnati M, Giavazzi R, Colombo G, Taraboletti G.

Thromb Res. 2016 Apr;140 Suppl 1:S182. doi: 10.1016/S0049-3848(16)30148-7. Epub 2016 Apr 8.

PMID:
27161705
5.

Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors.

Foglieni C, Pagano K, Lessi M, Bugatti A, Moroni E, Pinessi D, Resovi A, Ribatti D, Bertini S, Ragona L, Bellina F, Rusnati M, Colombo G, Taraboletti G.

Sci Rep. 2016 Mar 22;6:23432. doi: 10.1038/srep23432.

6.

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.

Pinessi D, Ostano P, Borsotti P, Bello E, Guffanti F, Bizzaro F, Frapolli R, Bani MR, Chiorino G, Taraboletti G, Resovi A.

Connect Tissue Res. 2015;56(5):355-63. doi: 10.3109/03008207.2015.1045065. Epub 2015 Jun 15.

PMID:
25943461
7.

Current understanding of the thrombospondin-1 interactome.

Resovi A, Pinessi D, Chiorino G, Taraboletti G.

Matrix Biol. 2014 Jul;37:83-91. doi: 10.1016/j.matbio.2014.01.012. Epub 2014 Jan 27. Review.

8.

Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies.

Bonezzi K, Belotti D, North BJ, Ghilardi C, Borsotti P, Resovi A, Ubezio P, Riva A, Giavazzi R, Verdin E, Taraboletti G.

Neoplasia. 2012 Sep;14(9):846-54.

9.

Targeting angiogenesis with compounds from the extracellular matrix.

Belotti D, Foglieni C, Resovi A, Giavazzi R, Taraboletti G.

Int J Biochem Cell Biol. 2011 Dec;43(12):1674-85. doi: 10.1016/j.biocel.2011.08.012. Epub 2011 Aug 17. Review.

PMID:
21864705

Supplemental Content

Loading ...
Support Center